Park Y H, Osmond D G
Department of Anatomy, McGill University, Montreal, Canada.
Cell Immunol. 1991 Jun;135(1):168-83. doi: 10.1016/0008-8749(91)90263-b.
An increase in pre-B cell proliferation and B lymphocyte production in mouse bone marrow has previously been shown to follow the administration of various foreign agents in vivo. The responses of early precursor B cells before the expression of mu chains (pro-B cells) have now been examined, using double immunofluorescence labeling for terminal deoxynucleotidyl transferase (TdT) and B220 glycoprotein as detected by monoclonal antibody 14.8. A single injection of sheep red blood cells (SRBC) was followed by an increase in the number of cells in three defined populations of early precursor B cells lacking mu chains (TdT+ 14.8- cells, TdT+ 14.8+ cells, and 14.8+ mu- cells) as well as cytoplasmic mu-bearing pre-B cells and surface mu-bearing B lymphocytes. An accompanying increase in proliferative activity was indicated by the numbers of 14.8+ mu- cells and pre-B cells which accumulated in metaphase after inducing mitotic arrest with vincristine. These effects were all abrogated either by treating mice with silica to depress macrophage function or by splenectomy. In mice given multiple injections of SRBC for 4 weeks the elevated levels of early precursor B cell production and B cell genesis were sustained. The work demonstrates that the in vivo production of early precursor B cells, putatively including those at the stage of Ig heavy chain gene rearrangement, can be stimulated by exposure to external agents acting indirectly by a silica-sensitive, spleen-dependent mechanism. The findings suggest that the level of pro-B cell proliferation and primary B cell genesis normally taking place in mouse bone marrow may reflect the level of exposure to potential stimulants in the external environment mediated by activation of splenic macrophages. The possibility that abnormally high levels of macrophage activation could predispose to dysregulations of the B cell lineage is raised.
先前已表明,给小鼠体内注射各种外源物质后,其骨髓中前B细胞增殖和B淋巴细胞生成会增加。现在,通过使用单克隆抗体14.8检测末端脱氧核苷酸转移酶(TdT)和B220糖蛋白的双重免疫荧光标记,对μ链表达之前的早期前体B细胞(前B细胞)的反应进行了研究。单次注射绵羊红细胞(SRBC)后,缺乏μ链的三个特定早期前体B细胞群体(TdT + 14.8-细胞、TdT + 14.8+细胞和14.8+μ-细胞)以及细胞质含μ的前B细胞和表面含μ的B淋巴细胞数量增加。用长春新碱诱导有丝分裂停滞之后,处于中期的14.8+μ-细胞和前B细胞数量表明增殖活性随之增加。用二氧化硅处理小鼠以抑制巨噬细胞功能或进行脾切除,均可消除这些效应。给小鼠多次注射SRBC持续4周后,早期前体B细胞生成和B细胞发生的升高水平得以维持。这项工作表明,早期前体B细胞的体内生成,可能包括那些处于Ig重链基因重排阶段的细胞,可以通过暴露于间接作用的外源物质而受到刺激,这种刺激是通过一种对二氧化硅敏感、依赖脾脏的机制实现的。这些发现表明,小鼠骨髓中正常发生的前B细胞增殖和初级B细胞发生水平,可能反映了由脾脏巨噬细胞激活介导的对外界环境中潜在刺激物的暴露水平。这就提出了巨噬细胞异常高水平激活可能导致B细胞谱系失调的可能性。